The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gout Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The global Gout Drugs market size is expected to reach US$ 6228.7 million by 2029, growing at a CAGR of 12.0% from 2023 to 2029. The market is mainly driven by the significant applications of Gout Drugs in various end use industries. The expanding demands from the Acute gout and Chronic gout, are propelling Gout Drugs market. Febuxostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzbromo Malone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gout Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gout Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gout Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gout Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gout Drugs covered in this report include Sun Pharma, Mylan, Apotex, Northstar, Ipca, Accord, Synpac-Kingdom, PIDI and KPC, etc.
The global Gout Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sun Pharma
Mylan
Apotex
Northstar
Ipca
Accord
Synpac-Kingdom
PIDI
KPC
Yunnan Phytopharmaceutical
Global Gout Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gout Drugs market, Segment by Type:
Febuxostat
Benzbromo Malone
Allopurinol
Colchicine
Other
Global Gout Drugs market, by Application
Acute gout
Chronic gout
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gout Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gout Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Gout Drugs market size is expected to reach US$ 6228.7 million by 2029, growing at a CAGR of 12.0% from 2023 to 2029. The market is mainly driven by the significant applications of Gout Drugs in various end use industries. The expanding demands from the Acute gout and Chronic gout, are propelling Gout Drugs market. Febuxostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzbromo Malone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gout Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gout Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gout Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gout Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gout Drugs covered in this report include Sun Pharma, Mylan, Apotex, Northstar, Ipca, Accord, Synpac-Kingdom, PIDI and KPC, etc.
The global Gout Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sun Pharma
Mylan
Apotex
Northstar
Ipca
Accord
Synpac-Kingdom
PIDI
KPC
Yunnan Phytopharmaceutical
Global Gout Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gout Drugs market, Segment by Type:
Febuxostat
Benzbromo Malone
Allopurinol
Colchicine
Other
Global Gout Drugs market, by Application
Acute gout
Chronic gout
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gout Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gout Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Gout Drugs Market Overview
1.1 Gout Drugs Product Overview
1.2 Gout Drugs Market Segment by Type
1.2.1 Febuxostat
1.2.2 Benzbromo Malone
1.2.3 Allopurinol
1.2.4 Colchicine
1.2.5 Other
1.3 Global Gout Drugs Market Size by Type
1.3.1 Global Gout Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Gout Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gout Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gout Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gout Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gout Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gout Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gout Drugs Sales Breakdown by Type (2018-2023)
2 Global Gout Drugs Market Competition by Company
2.1 Global Top Players by Gout Drugs Sales (2018-2023)
2.2 Global Top Players by Gout Drugs Revenue (2018-2023)
2.3 Global Top Players by Gout Drugs Price (2018-2023)
2.4 Global Top Manufacturers Gout Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gout Drugs Market Competitive Situation and Trends
2.5.1 Gout Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gout Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gout Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Gout Drugs Market
2.8 Key Manufacturers Gout Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gout Drugs Status and Outlook by Region
3.1 Global Gout Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gout Drugs Historic Market Size by Region
3.2.1 Global Gout Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Gout Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Gout Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gout Drugs Forecasted Market Size by Region
3.3.1 Global Gout Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Gout Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Gout Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gout Drugs by Application
4.1 Gout Drugs Market Segment by Application
4.1.1 Acute gout
4.1.2 Chronic gout
4.2 Global Gout Drugs Market Size by Application
4.2.1 Global Gout Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Gout Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gout Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gout Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gout Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gout Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gout Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gout Drugs Sales Breakdown by Application (2018-2023)
5 North America Gout Drugs by Country
5.1 North America Gout Drugs Historic Market Size by Country
5.1.1 North America Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gout Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Gout Drugs Sales in Value by Country (2018-2023)
5.2 North America Gout Drugs Forecasted Market Size by Country
5.2.1 North America Gout Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Gout Drugs Sales in Value by Country (2024-2029)
6 Europe Gout Drugs by Country
6.1 Europe Gout Drugs Historic Market Size by Country
6.1.1 Europe Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gout Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Gout Drugs Sales in Value by Country (2018-2023)
6.2 Europe Gout Drugs Forecasted Market Size by Country
6.2.1 Europe Gout Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Gout Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Gout Drugs by Region
7.1 Asia-Pacific Gout Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Gout Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gout Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gout Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gout Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Gout Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gout Drugs Sales in Value by Region (2024-2029)
8 Latin America Gout Drugs by Country
8.1 Latin America Gout Drugs Historic Market Size by Country
8.1.1 Latin America Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gout Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gout Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Gout Drugs Forecasted Market Size by Country
8.2.1 Latin America Gout Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gout Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Gout Drugs by Country
9.1 Middle East and Africa Gout Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Gout Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gout Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gout Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gout Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Gout Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gout Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sun Pharma
10.1.1 Sun Pharma Company Information
10.1.2 Sun Pharma Introduction and Business Overview
10.1.3 Sun Pharma Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sun Pharma Gout Drugs Products Offered
10.1.5 Sun Pharma Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Gout Drugs Products Offered
10.2.5 Mylan Recent Development
10.3 Apotex
10.3.1 Apotex Company Information
10.3.2 Apotex Introduction and Business Overview
10.3.3 Apotex Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Apotex Gout Drugs Products Offered
10.3.5 Apotex Recent Development
10.4 Northstar
10.4.1 Northstar Company Information
10.4.2 Northstar Introduction and Business Overview
10.4.3 Northstar Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Northstar Gout Drugs Products Offered
10.4.5 Northstar Recent Development
10.5 Ipca
10.5.1 Ipca Company Information
10.5.2 Ipca Introduction and Business Overview
10.5.3 Ipca Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ipca Gout Drugs Products Offered
10.5.5 Ipca Recent Development
10.6 Accord
10.6.1 Accord Company Information
10.6.2 Accord Introduction and Business Overview
10.6.3 Accord Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Accord Gout Drugs Products Offered
10.6.5 Accord Recent Development
10.7 Synpac-Kingdom
10.7.1 Synpac-Kingdom Company Information
10.7.2 Synpac-Kingdom Introduction and Business Overview
10.7.3 Synpac-Kingdom Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Synpac-Kingdom Gout Drugs Products Offered
10.7.5 Synpac-Kingdom Recent Development
10.8 PIDI
10.8.1 PIDI Company Information
10.8.2 PIDI Introduction and Business Overview
10.8.3 PIDI Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 PIDI Gout Drugs Products Offered
10.8.5 PIDI Recent Development
10.9 KPC
10.9.1 KPC Company Information
10.9.2 KPC Introduction and Business Overview
10.9.3 KPC Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 KPC Gout Drugs Products Offered
10.9.5 KPC Recent Development
10.10 Yunnan Phytopharmaceutical
10.10.1 Yunnan Phytopharmaceutical Company Information
10.10.2 Yunnan Phytopharmaceutical Introduction and Business Overview
10.10.3 Yunnan Phytopharmaceutical Gout Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Yunnan Phytopharmaceutical Gout Drugs Products Offered
10.10.5 Yunnan Phytopharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gout Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gout Drugs Industrial Chain Analysis
11.4 Gout Drugs Market Dynamics
11.4.1 Gout Drugs Industry Trends
11.4.2 Gout Drugs Market Drivers
11.4.3 Gout Drugs Market Challenges
11.4.4 Gout Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gout Drugs Distributors
12.3 Gout Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
